Oxford Cancer Biomarkers

Oxford Cancer is developing and commercialising a suite of colorectal cancer biomarker tests to improve the current treatment pathway.

Launch date

2012

Employees

Company register number SC379069

Oxford England (HQ)

http://oxfordbio.com

https://twitter.com/ocbiomarkers https://www.linkedin.com/company/oxford-cancer-biomarkers

Revenues, earnings & profits over time

EUR	2016	2018	2019	2020	2021	2022	2023
Revenues	<1m	<1m	<1m	<1m	<1m	<1m	<1m
% growth	-	-	112 %	27 %	4 %	13 %	11 %
EBITDA	(<1m)	(1.8m)	(2.6m)	(1.5m)	-	-	-
% EBITDA margin	(4751 %)	(1973 %)	(1353 %)	(628 %)	-	-	-
Profit	(<1m)	(1.4m)	(2.5m)	(1.2m)	-	-	-
% profit margin	(4952 %)	(1561 %)	(1322 %)	(512 %)	-	-	-

Date	Investors	Amount	Round
-	CRT Pioneer Fund OUI Startup Incubator	N/A	-
Jan 2012	Oxford University Innovation University of Oxford	N/A	Spinout
Dec 2015	Esperante Ventures	N/A	Seed
Jun 2019	Kwang Dong Pharmaceutical	N/A	Early VC
Mar 2023*	NHS England	£1.5m	Grant
Total Funding		€1.8m

Tech stackLearn more about the technologies and tools that this company uses.